One week after BAT launched its major global initiative to make a Smokeless World a reality, Dr Elaine Round, Global Head of Life Sciences at BAT, presented Omni™ at the Global Tobacco and Nicotine Forum (GTNF) in Athens, Greece - the world’s leading annual conference discussing the future of the tobacco and nicotine industries.
New multi-year research programme of BAT’s oral nicotine product Velo further demonstrates the product’s reduced-risk potential when used as a complete substitute for continued cigarette smoking